1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends

Pharma Clinical Trial Services: World Industry and Market Prospects 2015-2025

  • June 2015
  • 236 pages
  • Visiongain
Report ID: 3156590

Summary

Table of Contents

Please note: The license is valid for 12 months from the date the report is sent.


Report Details
Clinical Trials – Discover Commercial Potentials of Outsourced Drug Testing, Benefiting Your Authority
What does the future hold for pharmaceutical clinical research providers? Visiongain’s new study gives you multilevel revenue forecasts from 2015 to 2025. It explains trends, opportunities and selling prospects for that drug development and testing.

Our report predicts sales at overall world market, submarket and national level. There you find the most promising and lucrative parts of clinical trial outsourcing, helping your research and analysis. That way stay ahead, saving time and hassle, also benefiting your influence.

Clinical research organisations (CROs) and drug companies using them will benefit from expansion of that industry and market. Those technologies and outsourced services hold rising importance in pharmaceutical R&D. See why and how, finding the gains possible.

Read on, then, to explore those contracting services for benefiting medicine. Find what influences that market and see predicted revenue.

Forecasts and other analyses to help you stay ahead in knowledge
Why struggle to find information or miss data you need on clinical outsourcing and off-shoring? Instead reduce worry there, helping your searches, proposals and presentations.

So in our work discover where the money lies, and best places for business expansion. In that study you explore revenue forecasting to 2025, results and other statistics, growth rates, leading companies and market shares.

You also assess qualitative analysis (SWOT and STEP), news, business progress, outlooks and developmental needs – pharma R&D trends and demands. You find expected gains.

There you get 78 tables, 65 charts and interviews with three companies. The clinical testing market will increase its revenues from 2015 to 2025, achieving strong sales expansion. Our survey’s purpose is to explain those needs, opportunities and potentials.

That way you hear what’s happening, helping you stay ahead. And the following sections explain how our new investigation benefits your work.

Predictions for the world market and submarkets – what’s possible?
Along with revenue prediction for the overall world market, you see individual forecasts to 2025 for nine submarkets:
- Early phase services
- Late phase services
- Other related services (grouped).

You also get individual forecasts for contract clinical services at world level by therapeutic area:
- Cancer (oncology)
- Cardiovascular diseases
- CNS disorders
- Metabolic conditions
- Infective diseases
- Other treatment testing needs (grouped prediction).

There gain advantages by understanding trends, needs, opportunities and challenges. Our investigation shows what will stimulate and restrain CROs, helping you stay ahead in knowledge. That way, benefit your business and reputation for commercial insight.

Our work also divides its overall world sales forecast into geographical markets.

Clinical trial outsourcing – what prospects for research in leading regions and countries?
Demands worldwide from drug developers influence service providers from 2015, especially extending clinical research in developing countries. Many opportunities exist for pharmaceutical companies and contract research providers. See outlooks for clinical testing.

Our new study gives individual forecasts to 2025 for 12 national markets and a regional group, predicting overall revenues:
- United States (US)
- Japan
- Germany, France, UK, Italy and Spain (EU5 countries)
- Central and Eastern Europe (CEE, grouped forecast of that region)
- Brazil, Russia, India and China (BRIC nations) and South Korea.

There discover progress and commercial outlooks. You assess the industry’s future – hear about developments and find their significance. Our work explains, ex

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

eClinical Solutions Market by Product, Delivery Mode, Clinical Trial Phases, End User - Global Forecast to 2022

  • $ 5650
  • Industry report
  • April 2017
  • by MarketsandMarkets

“eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (On-Demand, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, ...

Pharmacovigilance Market Analysis By Clinical Trial Phase, By Service Provider, By Type, By End UseAnd Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • July 2017
  • by Grand View Research

Pharmacovigilance (PV) Market Analysis By Clinical Trial Phase (Pre-Clinical, Phase I, Phase II, Phase III, Phase IV), By Service Provider (In-House, Contract Outsourcing), By Type, By End UseAnd Segment ...

Clinical Trial Supplies Market Analysis By Phase, By Product & Services, By End-Use, By Therapeutic Use, By Region And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • July 2017
  • by Grand View Research

Clinical Trial Supplies Market Analysis By Phase (Phase I, Phase II, Phase III), By Product & Services (Manufacturing, Storage & Distribution, Supply Chain Management), By End-Use, By Therapeutic Use, ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.